Table 4.
General characteristics of the patients with renal insufficiency at the beginning and in the course of treatment
| Patient number | Age & gender | Time of RI | Type of RI | BUN, creatinine at the beginning of treatment | BUN, creatinine at the end of treatment | Concomitants nephrotoxic agent use | Type and duration of RRT | Duration of treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|
|
P4 |
11/M |
Before treatment |
Oliguric ARF |
36/1.3 |
23/1.6 |
Amphotericin B |
One day of hemodialysis |
19 |
Survey |
|
P8 |
7/M |
During the treatment |
Oliguric ARF |
8/0.2 |
53/5.6 |
Aminoglycoside, glycopeptides |
14 days of peritoneal dialysis |
22 |
Survey |
|
P12 |
2.5/F |
During the treatment |
Non-oliguric ARF |
7/0.2 |
20/1.6 |
Aminoglycoside |
Colistin treatment was halted |
8 |
Survey |
| RRT was not performed | |||||||||
|
P15 |
12/F |
During the treatment |
Non-oliguric ARF |
7/0.2 |
89/3.2 |
Glycopeptides, amphotericin B |
RRT was not performed |
8 |
Death* |
|
P26 |
17/M |
Before treatment |
CRF |
66/2.5 |
111/2.5 |
Non |
8 days of hemodialysis |
10 |
Death* |
| P38 | 7/M | Before treatment | ARF | 76/2.3 | 38/1.2 | Glycopeptides | 4 days of peritoneal dialysis | 4 | Death** |
*Infection-related death, **Infection-unrelated death, BUN: Blood urea nitrogen, RI: Renal impairment, RRT: Renal replacement therapy, ARF: Acute renal failure, CRF: Chronic renal failure.